Showing 541-550 of 1440 results for "".
Coming & Going: May/June 2023
https://modernaesthetics.com/ma-issues-index/2023-may-june/coming-going-mayjune-2023/35285/Modern Aesthetics Exclusive: The Ones to Watch
https://modernaesthetics.com/ma-issues-index/2023-may-june/modern-aesthetics-exclusive-the-ones-to-watch/35281/Meet the Six Companies That Peddled Their Wares at Octane’s Aesthetics Tech Forum 2023Should You Hire a Scribe?
https://modernaesthetics.com/ma-issues-index/2023-may-june/should-you-hire-a-scribe-1/35280/What to consider before bringing a scribe into your practice and the benefits of doing so.1 + 1 + 1 = 10: The Additive Effect of Combined Procedures
https://modernaesthetics.com/ma-issues-index/2023-may-june/1-1-1-10-the-additive-effect-of-combined-procedures/35279/Patients don’t care about the number of syringes you use—they just want to see results.How to Build a Better Sunscreen
https://modernaesthetics.com/ma-issues-index/2023-may-june/how-to-build-a-better-sunscreen-1/35278/Accessibility and personalization are key factors to building a better sunscreen.Now Hear This!
https://modernaesthetics.com/topics/practice-development/now-hear-this/35267/Your practice is on social media, but are you listening?Top 10 Takeaways Every IV Vitamin Therapy Practice Should Know About the Recent Revisions in USP 797
https://modernaesthetics.com/topics/practice-development/top-10-takeaways-every-iv-vitamin-therapy-practice-should-know-about-the-recent-revisions-in-usp-797/35262/Review the steps necessary to remain USP 797 compliant.Women in Aesthetics: Nicole Chiaramonte
https://modernaesthetics.com/topics/practice-development/women-in-aesthetics-nicole-chiaramonte/35259/Tax Diversification
https://modernaesthetics.com/topics/practice-development/tax-diversification/35251/An essential strategy for long-term wealth management.Dishing on a New Neuromodulator
https://modernaesthetics.com/topics/injectables/dishing-on-a-new-neuromodulator/35248/Sound strategies are required for patient counseling, dosing, and pricing with daxibotulinumtoxinA-lanm.